# Assessing the Efficacy of Probiotics in Prevention of NEC in Preterm Babies

> **NCT07233382** · NA · NOT_YET_RECRUITING · sponsor: **Hayatabad Medical Complex** · enrollment: 196 (estimated)

## Conditions studied

- NEC
- NEC - Necrotizing Enterocolitis

## Interventions

- **DRUG:** Probiotic
- **DRUG:** 10% dextrose

## Key facts

- **NCT ID:** NCT07233382
- **Lead sponsor:** Hayatabad Medical Complex
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12-01
- **Primary completion:** 2026-05-30
- **Final completion:** 2026-05-30
- **Target enrollment:** 196 (ESTIMATED)
- **Last updated:** 2025-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07233382

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07233382, "Assessing the Efficacy of Probiotics in Prevention of NEC in Preterm Babies". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07233382. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*